| Tumor evolution and drug response in patient-derived organoid models of bladder cancer SH Lee, W Hu, JT Matulay, MV Silva, TB Owczarek, K Kim, CW Chua, ... Cell 173 (2), 515-528. e17, 2018 | 654 | 2018 |
| Impact of hospital case volume on testicular cancer outcomes and practice patterns SL Woldu, JT Matulay, TN Clinton, N Singla, LM Krabbe, RC Hutchinson, ... Urologic Oncology: Seminars and Original Investigations 36 (1), 14. e7-14. e15, 2018 | 75 | 2018 |
| Micropapillary bladder cancer: insights from the National Cancer Database W Sui, JT Matulay, MB James, IC Onyeji, MC Theofanides, ... Bladder Cancer 2 (4), 415-423, 2016 | 65 | 2016 |
| Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma EJ Margolin, JT Matulay, G Li, X Meng, B Chao, V Vijay, H Silver, ... The Journal of Urology 199 (6), 1440-1445, 2018 | 63 | 2018 |
| Conservative management following complete clinical response to neoadjuvant chemotherapy of muscle invasive bladder cancer: contemporary outcomes of a multi-institutional … P Mazza, GW Moran, G Li, DJ Robins, JT Matulay, HW Herr, GJ Decastro, ... The Journal of urology 200 (5), 1005-1013, 2018 | 57 | 2018 |
| Collecting duct carcinoma of the kidney: disease characteristics and treatment outcomes from the National Cancer Database W Sui, JT Matulay, DJ Robins, MB James, IC Onyeji, A RoyChoudhury, ... Urologic Oncology: Seminars and Original Investigations 35 (9), 540. e13-540 …, 2017 | 55 | 2017 |
| Outcomes following clinical complete response to neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder in patients refusing radical cystectomy D Robins, J Matulay, M Lipsky, A Meyer, R Ghandour, G DeCastro, ... Urology 111, 116-121, 2018 | 42 | 2018 |
| Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer W Sui, JT Matulay, IC Onyeji, MC Theofanides, MB James, ... World Journal of Urology 35, 1055-1061, 2017 | 41 | 2017 |
| Long-term survival outcomes with intravesical nanoparticle albumin-bound paclitaxel for recurrent non–muscle-invasive bladder cancer after previous bacillus Calmette-Guérin therapy DJ Robins, W Sui, JT Matulay, R Ghandour, CB Anderson, GJ DeCastro, ... Urology 103, 149-153, 2017 | 41 | 2017 |
| Advances in risk stratification of bladder cancer to guide personalized medicine JT Matulay, AM Kamat F1000Research 7, 2018 | 40 | 2018 |
| The impact of squamous histology on survival in patients with muscle-invasive bladder cancer JT Matulay, SL Woldu, A Lim, VM Narayan, G Li, AM Kamat, CB Anderson Urologic Oncology: Seminars and Original Investigations 37 (6), 353. e17-353 …, 2019 | 39 | 2019 |
| Risk‐adapted management of low‐grade bladder tumours: Recommendations from the international bladder cancer group (IBCG) JT Matulay, M Soloway, JA Witjes, R Buckley, R Persad, DL Lamm, ... BJU international 125 (4), 497-505, 2020 | 38 | 2020 |
| Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus Calmette-Guérin: implications for clinical trial design JT Matulay, R Li, PJ Hensley, NA Brooks, VM Narayan, HB Grossman, ... The Journal of urology 205 (6), 1612-1621, 2021 | 36 | 2021 |
| Urinary tract infections in women: pathogenesis, diagnosis, and management JT Matulay, CM Mlynarczyk, KL Cooper Current Bladder Dysfunction Reports 11, 53-60, 2016 | 36 | 2016 |
| Timing and predictors of early urologic and infectious complications after renal transplant: an analysis of a New York statewide database W Sui, MJ Lipsky, JT Matulay, DJ Robins, IC Onyeji, MB James, ... Exp Clin Transplant 16 (6), 665-670, 2018 | 29 | 2018 |
| Vesicovaginal fistulas in the developed world: An analysis of disease characteristics, treatments, and complications of surgical repair using the ACS‐NSQIP database MC Theofanides, W Sui, EM Sebesta, I Onyeji, JT Matulay, DE Chung Neurourology and Urodynamics 36 (6), 1622-1628, 2017 | 26 | 2017 |
| Predicting renal parenchymal loss after nephron sparing surgery A Meyer, SL Woldu, AC Weinberg, GR Thoreson, P Pierorazio, JT Matulay, ... The Journal of Urology 194 (3), 658-663, 2015 | 26 | 2015 |
| Evidence-based urology P Dahm, R Dmochowski John Wiley & Sons, 2018 | 25 | 2018 |
| Clinical and genomic considerations for variant histology in bladder cancer JT Matulay, VM Narayan, AM Kamat Current oncology reports 21, 1-9, 2019 | 23 | 2019 |
| Utilization of preoperative laboratory testing for low-risk, ambulatory urologic procedures W Sui, MC Theofanides, JT Matulay, MB James, IC Onyeji, ... Urology 94, 77-84, 2016 | 22 | 2016 |
